Press release
Oncology Molecular Diagnostics Market Set for Strong Growth to USD 6.46 Billion by 2033, Led by North America's 44.27% Market Share | Key Players - Abbott, QIAGEN, F. Hoffmann-La Roche Ltd
Oncology Molecular Diagnostics Market
Market growth is driven by the surging global cancer burden, rising demand for personalized medicine, and advancements in genomic sequencing technologies like NGS and PCR-based assays. Expanding applications in companion diagnostics, liquid biopsies for early detection, and immunotherapy response prediction, coupled with increased R&D investments and favorable reimbursements, are propelling the market forward.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/oncology-molecular-diagnostics-market?ram
Key Industry Developments
United States:
✅ January 2026: Guardant Health launched Guardant Reveal 360, an advanced liquid biopsy test enhancing multi-cancer early detection through comprehensive ctDNA analysis and AI-driven methylation profiling for improved sensitivity across stages.
✅ December 2025: Illumina introduced TruSight Oncology 500 HT, a next-generation sequencing assay expanding tissue and liquid biopsy capabilities with broader gene coverage for precise tumor profiling and therapy matching.
✅ November 2025: Roche expanded the FoundationOne CDx approval for novel oncology indications, integrating multiplex PCR and NGS for companion diagnostics supporting immunotherapy response prediction.
Asia Pacific / Japan:
✅ January 2026: Sysmex Corporation unveiled OncoGuide NCC Panel in Japan, a comprehensive NGS-based cancer gene panel tailored for Asian populations with region-specific mutation detection for personalized treatment.
✅ December 2025: Fujifilm launched a novel ISH-based molecular diagnostic kit for HER2 and PD-L1 in lung cancer, improving accuracy in Japanese clinical settings through automated imaging advancements.
✅ October 2025: Chugai Pharmaceutical announced R&D milestone in CRISPR-enhanced ctDNA assays for minimal residual disease monitoring, partnering with Japanese hospitals for oncology trials.
Key Players:
Abbott | QIAGEN | F. Hoffmann-La Roche Ltd | BD | Cepheid | Hologic, Inc. | Sysmex Corporation | Bio-Rad Laboratories, Inc. | Foundation Medicine, Inc. | ASURAGEN, INC.
Strategic Leadership Report: Top 5 Players in Oncology Molecular Diagnostics Market 2026
-Abbott: Launched the Alinity m IFU series for oncology, integrating high-throughput molecular testing for HPV and other cancer biomarkers to enable faster, more precise tumor profiling in clinical workflows.
-QIAGEN: Introduced the QIAcuity digital PCR system with upgraded oncology panels, delivering absolute quantification of low-frequency mutations like EGFR and KRAS for improved liquid biopsy accuracy in precision cancer care.
-F. Hoffmann-La Roche Ltd: Rolled out the AVENIO Tumor Tissue NGS kits, expanding comprehensive genomic profiling for solid tumors with enhanced detection of actionable variants to guide targeted therapies.
-Cepheid: Deployed the Xpert BCR-ABL Ultra assay on GeneXpert systems, providing rapid quantitative monitoring of chronic myeloid leukemia treatment response with superior sensitivity for minimal residual disease.
-Foundation Medicine: Advanced the FoundationOne CDx with new companion diagnostic indications for colorectal and breast cancers, supporting immunotherapy decisions through AI-enhanced analysis of over 300 cancer-related genes.
Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=oncology-molecular-diagnostics-market?ram
Market Drivers and Key Trends:
-Rising Cancer Incidence: Escalating global cancer cases, driven by aging populations and lifestyle factors, boost demand for early, precise molecular diagnostics like PCR and NGS for better patient outcomes.
-Precision Medicine Shift: Adoption of companion diagnostics and liquid biopsies enables targeted therapies by identifying specific mutations, accelerating personalized oncology care.
-Technological Advancements: Innovations in next-generation sequencing (NGS) and PCR enhance diagnostic accuracy and speed, supporting comprehensive genomic profiling.
-Genomics Initiatives: National programs in Asia-Pacific, like China's precision medicine plan, expand access via reimbursement and lower costs through public-private partnerships.
Regional Insights:
-North America: 44.27% (Largest share, driven by high cancer prevalence in the US, advanced diagnostic adoption, and strong regulatory support).
-Asia Pacific: 25% (Fastest growing at 6.7% CAGR, fueled by rising cancer cases, healthcare infrastructure improvements, and precision medicine awareness in China, India, and Japan).
-Europe: 20% (Supported by steady investments in genomics and national reimbursement initiatives).
-Latin America: 6% (Moderate growth from expanding screening programs in Brazil and Mexico).
-Middle East & Africa: 5% (Emerging expansion via public-private partnerships in Saudi Arabia and South Africa).
Market Opportunities & Challenges: Oncology Molecular Diagnostics Market 2026
-Opportunities: A "Liquid Biopsy Leap" accelerates non-invasive monitoring; the ctDNA segment projects a 15.2% CAGR through national screening expansions in Asia-Pacific. NGS platform subsidies and AI-pathology integrations via public-private genomic consortia enable precision oncology scale-up for targeted therapy companions.
-Challenges: "Reimbursement Rigidity" persists amid high NGS assay costs, while workforce shortages in genomic interpretation strain hospital adoption. Fragmented EHR integrations and rural access gaps demand localized assay validation to counter equity divides.
-Strategic Verdict: High-margin liquid biopsy and AI-enhanced companion diagnostics are the core growth vectors for 2026.
Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/oncology-molecular-diagnostics-market?ram
Market Segmentation Analysis:
-By Product Type: Reagents Dominate with High Volume Demand
Reagents lead at 55% market share in 2025, essential for routine testing due to consumable nature and scalability in labs.
Instruments follow at 30%, enabling advanced detection but limited by high upfront costs.
Software claims 15%, supporting data analysis and integration in diagnostics workflows.
-By Technology: PCR Holds Largest Share for Reliability
PCR commands 45% share, valued for speed, sensitivity, and cost-effectiveness in gene amplification for cancer detection.
NGS captures 30%, surging for comprehensive genomic profiling despite complexity.
ISH takes 15%, key for visualizing gene expressions spatially; Others (e.g., microarrays) hold 10%.
-By Application: Breast Cancer Leads Amid Early Detection Push
Breast cancer dominates at 25% share, driven by high incidence and screening programs like HER2 testing.
Lung cancer follows at 20%, boosted by smoking trends and EGFR mutations.
Colorectal (15%), prostate (12%), blood (10%), liver (8%), cervical (5%), and others (5%) trail, with blood cancer rising via liquid biopsies.
Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?ram
Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.
✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring
Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTW
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Oncology Molecular Diagnostics Market Set for Strong Growth to USD 6.46 Billion by 2033, Led by North America's 44.27% Market Share | Key Players - Abbott, QIAGEN, F. Hoffmann-La Roche Ltd here
News-ID: 4382055 • Views: …
More Releases from DataM intelligence 4 Market Research LLP
Future of Ion Channel Modulators Market Growth (2026-2033) | Majore Players - Zy …
DataM Intelligence released its latest game-changing report "Ion Channel Modulators Market Size 2025" Packed with actionable insights for decision-makers, this report goes beyond numbers to decode regional growth hotspots, high-potential market segments, CAGR forecasts, revenue performance of leading players, and the real drivers steering the industry forward. Whether you're an investor, manufacturer, distributor, or technology strategist, this report delivers a crystal-clear, telescopic outlook on market size (value & volume), Growth…
Carbon Capture, Utilization and Storage Market to Reach US$ 16.5 Billion by 2031 …
Carbon Capture, Utilization and Storage Market reached US$ 3.0 billion in 2023 and is expected to reach US$ 16.5 billion by 2031, growing at a CAGR of 24.0% during the forecast period 2024 to 2031.
The market is gaining strong momentum as rising global awareness of climate change and the urgent need to reduce carbon dioxide emissions accelerate adoption of CCUS technologies. Public engagement initiatives, community outreach programs, and sustainability education…
China Contact Lenses Market Growth 2031 | Cosmetic, Ortho-K, and Disposable Segm …
DataM Intelligence released its latest game-changing report "China Contact Lenses Market Size 2025" Packed with actionable insights for decision-makers, this report goes beyond numbers to decode regional growth hotspots, high-potential market segments, CAGR forecasts, revenue performance of leading players, and the real drivers steering the industry forward. Whether you're an investor, manufacturer, distributor, or technology strategist, this report delivers a crystal-clear, telescopic outlook on market size (value & volume), Growth…
Digital Transformation Market to Reach US$ 3035.5 Billion by 2030 at 23.0% CAGR …
Digital Transformation Market reached US$ 910 billion in 2024 and is expected to reach US$ 3035.5 billion by 2030, growing at a CAGR of 23.0% during the forecast period 2025 to 2030.
The market is expanding rapidly as organizations across industries accelerate adoption of cloud computing, artificial intelligence, data analytics, Internet of Things, and automation technologies to enhance operational efficiency and customer experience. Enterprises are prioritizing digital first strategies to modernize…
More Releases for NGS
Next Generation Sequencing (NGS) : - Key Industry Dynamics
The Next Generation Sequencing (NGS) market size is projected to reach US$ 34.75 billion by 2031 from US$ 10.00 billion in 2023. The market is expected to register a CAGR of 16.8% during 2023-2031. Increased throughput and reduced costs is likely to remain key trends in the market.
Next-generation sequencing (NGS) carries a shift in genomics research, offering unmatched capabilities for analyzing DNA and RNA molecules in a high-throughput and cost-effective…
Next-Generation Sequencing (NGS) Services Next-Generation Sequencing (NGS) Servi …
Global Next-Generation Sequencing (NGS) Services Market Report encompasses market data, such as trends, consumer behavior, and competitive analysis in a way that allows businesses to identify opportunities in the market. The objective of the market research is understood very clearly by DBMR team before the creation of report commences. Intense research takes place to accurately analyze market dynamics and consumer behaviour included in the report.
Global Next-Generation Sequencing (NGS) Services Market,…
Complete PDF Guide to NGS Sample Preparation
The NGS sample preparations determine components in the samples, such as blood, urine, and others, in animals.
𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐏𝐃𝐅 @ https://www.theinsightpartners.com/sample/TIPRE00006573?utm_source=OpenPR&utm_medium=10379
The type of analyzers includes urine analyzers, blood gas & electrolyte analyzers, glucometers, and others used by medical labs, hospitals, and people at home.
Top Companies Analysis -
Agilent Technologies, Inc.
Becton, Dickinson and Company
Beckman Coulter
F. Hoffmann-La Roche AG
Illumina, Inc.
…
NGS Sample Preparation Market - Preparing for Precision: NGS Sample Preparation …
Newark, New Castle, USA: The "NGS Sample Preparation Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
NGS Sample Preparation Market: https://www.growthplusreports.com/report/ngs-sample-preparation-market/8504
This latest report researches the industry structure,…
NGS Library Preparation Market - Sequencing Solutions, Redefined: Innovations in …
Newark, New Castle, USA - new report, titled NGS Library Preparation Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the NGS Library Preparation market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global NGS Library Preparation market. The report offers an overview of…
Next Generation Sequencing (NGS) Data Analysis Market Research Report 2020Next G …
The Next Generation Sequencing (NGS) Data Analysis Market report helps identify the biggest opportunities in Next Generation Sequencing (NGS) Data Analysis industry space and offers accurate latent demand forecasting that empowers quantitative decision making among Next Generation Sequencing (NGS) Data Analysis market players and new entrants. Investors will gain a clear insight on the dominant players in Next Generation Sequencing (NGS) Data Analysis industry and their future forecasts. Furthermore, readers…
